Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 1/20 | 0.67 |
| ▸ | PPARD | Q03181 | 1/20 | 0.67 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.67 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.67 |
| ▸ | ZDHHC7 | Q9NXF8 | 2/20 | 0.60 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.42 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5974589 | 1.00 | LCK (0.67) | LCKPPARDZDHHC20ZDHHC2ZDHHC7 | |
| SCHEMBL7949690 | 1.00 | LCK (0.67) | LCKPPARDZDHHC20ZDHHC2ZDHHC7 | |
| SCHEMBL8451807 | 1.00 | LCK (0.67) | LCKPPARDZDHHC20ZDHHC2ZDHHC7 | |
| SCHEMBL10656314 | 1.00 | LCK (0.67) | LCKPPARDZDHHC20ZDHHC2ZDHHC7 | |
| SCHEMBL18300692 | 0.98 | LCK (0.63) | LCKPPARDZDHHC20ZDHHC2ZDHHC7 | |
| SCHEMBL306336 | 0.91 | — | — | |
| SCHEMBL9583527 | 0.83 | LCK (0.45) | LCKPPARDZDHHC20ZDHHC2ZDHHC7 | |
| SCHEMBL4968295 | 0.81 | — | — | |
| SCHEMBL23829555 | 0.80 | LCK (1.00) | LCKPPARDZDHHC20ZDHHC2ZDHHC7 | |
| SCHEMBL2721068 | 0.80 | LCK (1.00) | LCKPPARDZDHHC20ZDHHC2ZDHHC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109535354-B | Nanocluster with bactericidal effect and preparation method and application thereof | 合肥工业大学 | 2021-01-15 | — | — | CN | claimed |
| EP-3611270-B1 | KITS FOR IN VITRO ANTIGEN PRESENTATION, ASSESSING VACCINE EFFICACY, AND ASSESSING IMMUNOTOXICITY OF BIOLOGICS AND DRUGS | UNIV MIAMI (US) | 2021-12-01 | — | — | EP | disclosed |
| CN-109535354-B | Nanocluster with bactericidal effect and preparation method and application thereof | 合肥工业大学 | 2021-01-15 | — | — | CN | disclosed |
| EP-3611270-A1 | KITS FOR IN VITRO ANTIGEN PRESENTATION, ASSESSING VACCINE EFFICACY, AND ASSESSING IMMUNOTOXICITY OF BIOLOGICS AND DRUGS | University Of Miami (US) | 2020-02-19 | — | — | EP | disclosed |
| US-20190170742-A1 | COMPOSITIONS, KITS AND METHODS FOR IN VITRO ANTIGEN PRESENTATION, ASSESSING VACCINE EFFICACY, AND ASSESSING IMMUNOTOXICITY OF BIOLOGICS AND DRUGS | UNIV MIAMI (US) | 2019-06-06 | — | — | US | disclosed |
| EP-2432893-B1 | COMPOSITIONS, KITS AND METHODS FOR IN VITRO ANTIGEN PRESENTATION, ASSESSING VACCINE EFFICACY, AND ASSESSING IMMUNOTOXICITY OF BIOLOGICS AND DRUGS | UNIV MIAMI (US) | 2019-05-01 | — | — | EP | disclosed |
| US-20170146526-A1 | COMPOSITIONS, KITS AND METHODS FOR IN VITRO ANTIGEN PRESENTATION, ASSESSING VACCINE EFFICACY, AND ASSESSING IMMUNOTOXICITY OF BIOLOGICS AND DRUGS | UNIV MIAMI (US) | 2017-05-25 | — | — | US | disclosed |
| US-20120129199-A1 | COMPOSITIONS, KITS AND METHODS FOR IN VITRO ANTIGEN PRESENTATION, ASSESSING VACCINE EFFICACY, AND ASSESSING IMMUNOTOXICITY OF BIOLOGICS AND DRUGS | UNIVERSITY OF MIAMI (US) | 2012-05-24 | — | — | US | disclosed |
| EP-2432893-A1 | COMPOSITIONS, KITS AND METHODS FOR IN VITRO ANTIGEN PRESENTATION, ASSESSING VACCINE EFFICACY, AND ASSESSING IMMUNOTOXICITY OF BIOLOGICS AND DRUGS | University Of Miami (US) | 2012-03-28 | — | — | EP | disclosed |
| WO-2010135394-A1 | COMPOSITIONS, KITS AND METHODS FOR IN VITRO ANTIGEN PRESENTATION, ASSESSING VACCINE EFFICACY, AND ASSESSING IMMUNOTOXICITY OF BIOLOGICS AND DRUGS | UNIVERSITY OF MIAMI (US) | 2010-11-25 | — | — | WO | disclosed |
| EP-0152935-B1 | PROCESS FOR PREPARING 2,2,6,6-TETRAMETHYL-4-OXOPIPERIDINE | ADEKA ARGUS CHEMICAL CO., Ltd. (JP) | 1988-11-30 | — | — | EP | disclosed |
| EP-0152934-B1 | METHOD FOR PREPARING 2,2,6,6-TETRAMETHYL-4-OXOPIPERIDINE | ADEKA ARGUS CHEMICAL CO., Ltd. (JP) | 1988-09-14 | — | — | EP | disclosed |
| US-4663459-A | FROM AMMONIA AND ACETONE WITH ACYLHALIDE CATALYST | ADEKA ARGUS CHEMICAL CO., LTD. (JP) | 1987-05-05 | — | — | US | disclosed |
| US-4661597-A | FROM ACETONE AND ACETONING WITH AN ORGANIC ACID HALIDE CATALYST | ADEKA ARGUS CHEMICAL CO., LTD. (JP) | 1987-04-28 | — | — | US | disclosed |
| EP-0152935-A1 | Process for preparing 2,2,6,6-tetramethyl-4-oxopiperidine | ADEKA ARGUS CHEMICAL CO., Ltd. (JP) | 1985-08-28 | — | — | EP | disclosed |
| EP-0152934-A1 | Method for preparing 2,2,6,6-tetramethyl-4-oxopiperidine | ADEKA ARGUS CHEMICAL CO., Ltd. (JP) | 1985-08-28 | — | — | EP | disclosed |